RTTNews | Nov 15, 2021 06:04AM EST

06:04 Monday, November 15, 2021 (RTTNews) - AcelRx Pharma Q3 Loss Per Share $0.07; Announces Execution Of Definitive Merger Deal To Acquire Lowell Therapeutics

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved